Depression, OCD, and PTSD are the main psychiatric indications which benefit from ketamine, although other psychiatric indications can be discussed on a case-by-case basis.
*KETAMINE IS NOT FDA APPROVED TO TREAT ANY OF THE ABOVE CONDITIONS
No. Ketamine is not FDA approved for any other indication that for use as an anesthetic. That being said, it is not uncommon for medications that are approved for a certain indication, to be prescribed for another indication. Physician’s are able to use their clinical judgement to use FDA approved medications for non-indicated uses. This is generally referred to as prescribing “off-label.” Ketamine was FDA approved for use as an anesthetic in 1970, but over the last 20+ years a growing body of research that has strong evidence that it is effective for other conditions such as depression.
Contact the Ketamine For Life clinic to arrange an appointment for a consultation. You will spend approximately 1 hour with the provider discussing your situation, your medical history, the risks, benefits, and alternatives associated with ketamine.
Our office staff can discuss very basic information and guidelines over the phone, so to really find out whether or not you are an appropriate candidate for ketamine, you need to discuss your unique situation during the consultation.
No. Patients may refer themselves, but it is required that patients have a consultation at Ketamine For Life prior to receiving ketamine treatments even if they have had ketamine treatments done at another physician’s office.
There is no significant difference in the outcome between IV and IM ketamine administration methods. There are several differences that may make patients choose one over the other. The differences are discussed during the consultation.
An initial 12 treatments over the course of 10 weeks are recommended for treating depression, and other psychiatric conditions. The details of this initial treatment protocol (i.e., dosing, scheduling, etc) will be discussed thoroughly during the the initial consultation. These first 12 treatments are broken down into 2 phases called Induction Phase 1 (IP1), and Induction Phase 2 (IP2). Response or remission at the end of IP1 is required to move into IP2. If there is response or remission of symptoms after IP2 patients will move on to the Maintenance Phase (MP). MP consists of 1 treatment every 2-5 weeks. Deviations from our protocol are not recommended but can be done on a case-by-case basis.
Very few medical and psychiatric conditions make ketamine infusion treatments contraindicated. History of schizophrenia, pregnancy, ongoing drug and alcohol misuse/abuse, uncontrolled blood pressure, glaucoma, and previous allergic reactions to ketamine will exclude people from being candidates for ketamine infusions. Additionally, unmanaged chronic medical conditions may exclude people from ketamine treatments, such as diabetes, cardiac or pulmonary disease, obesity (BMI 40 or higher), etc.
Note regarding blood pressure: The most common medical condition that prevents and/or interferes with ketamine treatments is uncontrolled hypertension, therefore it is encouraged for patients considering ketamine treatments to ensure their blood pressure is well controlled. They should consult their primary care physician if there is any question regarding the status of their blood pressure. Ketamine infusions can not be administered to persons with abnormal blood pressure on the day of the treatment. Our protocols regarding blood pressure are very strict.
It is highly unlikely. There is no evidence of any increased risk for abuse of ketamine in patients that have been treated for psychiatric conditions or chronic pain with IV ketamine infusions.
You are not allowed to drive until the morning following your appointment, and you should avoid illegal drugs and alcohol for 24 hours as well. You will need to arrange for transportation home from the clinic following the treatment.
Yes and no. We are “in network” with most insurance plans and can bill any required psychiatric evaluations and assessments directly to the insurance companies. However, because ketamine infusions for depression is a non-FDA approved indication, the insurance companies view it as investigational and/or experimental and will not cover this treatment.
For details on pricing, see our pricing page of this site, which can be found HERE.
Primary psychiatric services are offered by Dr. Jake Hollingsworth and by Physician Assistant, Robert Bennett. In addition we offer transcranial magnetic stimulation (TMS) and theta burst stimulation (TBS). We also offer injectable nutrient therapies such as IV nutrient infusions and IM injections. We are currently in the process of implementing the recently FDA-approved intra-nasal antidepressant Spravato™ (esketamine).
Learn more about our other treatment modalities at our primary website: Pacific Psychiatric Intervention & Wellness Centers